GENENTECH OFFERING DISCOUNTS ON HUMAN GROWTH HORMONE IN BREAK FROM PAST PRACTICES; PULMOZYME PE AND QoL DATA ARE CENTRAL IN COVERAGE NEGOTIATIONS
Executive Summary
Genentech is reconsidering its no discount policy in individual negotiations with purchasers, particularly for its human growth hormone products. Genentech Senior Director of Government Affairs Walter Moore indicated the shift in approach in comments to the Health Industry Group Purchasing Association Pharmacy Forum in New Orleans on May 5.